Karl Erik Jansson

USPTO Granted Patents = 13 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 175(Granted Patents)

Company Filing History:

Teva Pharmaceutical Industries Limited

patents

3 out of 93

Acadia Pharmaceuticals Inc.

where one patent can have more than one assignee

Years Active: 2002-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12139477 - Compounds, salts thereof and methods for treatment of diseases (2024-11-12),

2. 11440884 - Compounds, salts thereof and methods for treatment of diseases (2022-09-13),

3. 11345693 - Compounds, salts thereof and methods for treatment of diseases (2022-05-31),

4. 9340307 - Stable laquinimod preparations (2016-05-17),

5. 8754104 - Crystalline salts of quinoline compounds and methods for preparing them (2014-06-17),

6. 8545885 - Stable laquinimod preparations (2013-10-01),

7. 8314124 - Crystalline salts of quinoline compounds and methods for preparing them (2012-11-20),

8. 8178127 - Stable laquinimod preparations (2012-05-15),

9. 7589208 - Compositions containing quinoline compounds (2009-09-15),

10. 7560557 - Process for the manufacture of quinoline derivatives (2009-07-14),

11. 7553849 - Compounds (2009-06-30),

12. 6875869 - Process for the manufacture of quinoline derivatives (2005-04-05),

13. 6395750 - Drugs for the treatment of malignant tumors (2002-05-28),

Title: The Innovative Contributions of Karl Erik Jansson in Pharmaceutical Patents

Introduction

Karl Erik Jansson, located in Dalby, Sweden, is a noteworthy inventor in the field of pharmaceuticals, with a remarkable portfolio of 13 patents. His work primarily focuses on compounds and methods aimed at treating various diseases, showcasing his significant contributions to medical science and innovation.

Latest Patents

Among his latest patents, Jansson has developed compounds and salts useful for the treatment of diseases. These patents include detailed disclosures regarding compounds according to specific formulas, emphasizing their potential application in therapeutic settings. His innovation is particularly relevant in the realm of medicine, where novel treatment methods can significantly impact patient care.

Career Highlights

Throughout his career, Jansson has collaborated with several prominent companies in the pharmaceutical industry, including Active Biotech AB and Teva Pharmaceutical Industries Limited. His work at these organizations has allowed him to develop critical innovations that advance medical treatment options and improve patient outcomes.

Collaborations

In his journey as an inventor, Karl Erik Jansson has worked alongside notable colleagues such as Tomas Fristedt and Anders Björk. These collaborations have undoubtedly enriched his research endeavors and facilitated the development of groundbreaking pharmaceutical solutions.

Conclusion

Karl Erik Jansson's inventive spirit and dedication to medical advancements have led to substantial contributions in the field of pharmaceuticals. With his extensive patent portfolio and collaborative efforts, he continues to pave the way for innovative treatments that hold promise for the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.